Gary Middleton

Colleges, School and Institutes

View graph of relations

Most downloaded publications

Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
Gary Middleton, 4 Feb 2016, In: British Journal of Cancer.

Research output: Contribution to journal › Article › peer-review

681 downloads
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
& 31 others, , Gary Middleton, 25 May 2017, In: Nature. 545, 7655, p. 446-451 6 p.

Research output: Contribution to journal › Article › peer-review

652 downloads
Tracking the Evolution of Non-Small-Cell Lung Cancer
& 63 others, , Babu Naidu, Gary Middleton, 1 Jun 2017, In: New England Journal of Medicine. 376, 22, p. 2109-2121

Research output: Contribution to journal › Article › peer-review

507 downloads
An immunogenomic stratification of colorectal cancer : implications for development of targeted immunotherapy
Andrew Beggs, Benjamin Willcox & Gary Middleton, 2 Apr 2015, In: OncoImmunology. 4, 3, e976052.

Research output: Contribution to journal › Article › peer-review

332 downloads
The National Lung Matrix Trial : translating the biology of stratification in advanced non-small-cell lung cancer
Gary Middleton & Lucinda Billingham, 12 Dec 2015, In: Annals of Oncology. 26, 12, p. 2464-2469

Research output: Contribution to journal › Article › peer-review

222 downloads

Recent publications

NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotype
Jianmin Zuo, Hayden Pearce, Sandra Davies, Gary Middleton & Paul Moss, 19 Nov 2020, In: OncoImmunology. 9, 1

Research output: Contribution to journal › Article › peer-review

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Oct 2020, In: The Lancet Oncology. 21, 10, p. 1309-1316 8 p.

Research output: Contribution to journal › Article › peer-review

Utility of COVID-19 screening in cancer patients
14 Sep 2020, In: Cancer Cell. 38, 3, p. 306-307 2 p.

Research output: Contribution to journal › Letter › peer-review

View all (76)

Recent Activities

A Phase II Clinical Trial with Efficacy and Toxicity Outcomes and Baseline Covariates

Kristian Brock (Speaker), Lucinda Billingham (Contributor), Gary Middleton (Contributor) & Christina Yap (Contributor)

2 Jul 2018

Activity: Talk or presentation › Academic conference

Design dilemmas in the multi-drug, genetic-marker-directed, non-comparative, multi-centre, multi-arm phase II National Lung Matrix Trial

Lucinda Billingham (Invited speaker), (Invited speaker), Kristian Brock (Invited speaker), (Invited speaker) & Gary Middleton (Invited speaker)

26 Aug 2014

Activity: Talk or presentation › Academic conference

View all (2)